Cargando…
Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
Response to tyrosine kinase inhibitor (TKI) therapy in patients with chronic myeloid leukemia (CML) is monitored by quantification of BCR::ABL1 transcript levels. Milestones for assessing optimal treatment response have been defined in adult CML patients and are applied to children and adolescents a...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598002/ https://www.ncbi.nlm.nih.gov/pubmed/37875583 http://dx.doi.org/10.1038/s41598-023-45364-0 |